CRISPR/Cas9 editing in human pluripotent stem cell-cardiomyocytes highlights arrhythmias, hypocontractility, and energy depletion as potential therapeutic targets for hypertrophic cardiomyopathy

Supporters

Support the authors with ResearchCoin

Tip RSC

Journal

European Heart Journal

Topics

Biology

Internal Medicine

Medicine

Cardiology And Cardiovascular Medicine

Molecular Biology

Show all topics

DOI

10.1093/eurheartj/ehy249

License

CC-BY

Other Formats

PDF